SanBio Company Limited
SNBIF
$16.45
$2.1715.20%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 8.44M | 10.74M | 10.74M | 11.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 20.08M | 25.93M | 25.93M | 32.47M |
| Operating Income | -- | -20.08M | -25.93M | -25.93M | -32.47M |
| Income Before Tax | -- | -12.20M | -11.16M | -11.16M | -18.26M |
| Income Tax Expenses | -- | 2.02M | 3.94M | 3.94M | 581.10K |
| Earnings from Continuing Operations | -- | -14.22 | -15.10 | -15.10 | -18.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -14.22M | -15.10M | -15.10M | -18.85M |
| EBIT | -- | -20.08M | -25.93M | -25.93M | -32.47M |
| EBITDA | -- | -19.98M | -25.81M | -25.81M | -32.33M |
| EPS Basic | -- | -0.21 | -0.23 | -0.23 | -0.29 |
| Normalized Basic EPS | -- | -0.13 | -0.12 | -0.12 | -0.19 |
| EPS Diluted | -- | -0.21 | -0.23 | -0.23 | -0.29 |
| Normalized Diluted EPS | -- | -0.13 | -0.12 | -0.12 | -0.19 |
| Average Basic Shares Outstanding | -- | 268.80M | 265.08M | 265.08M | 261.29M |
| Average Diluted Shares Outstanding | -- | 268.80M | 265.08M | 265.08M | 261.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |